<DOC>
	<DOCNO>NCT02862600</DOCNO>
	<brief_summary>The purpose study evaluate effect perhexiline exercise performance ( efficacy ) safety patient hypertrophic cardiomyopathy moderate-to-severe heart failure follow dose 16 week .</brief_summary>
	<brief_title>Open-Label Study Perhexiline Patients With Hypertrophic Cardiomyopathy Moderate Severe Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy , Hypertrophic</mesh_term>
	<mesh_term>Cardiomyopathy , Hypertrophic , Familial</mesh_term>
	<mesh_term>Perhexiline</mesh_term>
	<criteria>Key Hypertrophic cardiomyopathy symptom moderatetosevere heart failure Left ventricular hypertrophy maximum LV wall thickness ≥ 15 mm Left ventricular ejection fraction ≥ 50 % Able perform exercise test unable exceed 75 % predict ageadjusted maximum level Key CYP2D6 Poor Metabolizer ( PM ) status History know chronic liver disease ALT , AST , alkaline phosphatase , LDH &gt; 1.5 x upper limit normal Total Bilirubin &gt; 2.0 x upper limit normal Severe LV outflow obstruction Asymptomatic patient cardiomyopathyrelated criterion per protocol QT interval relate criterion per protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>hypertrophic cardiomyopathy</keyword>
	<keyword>hypertrophic</keyword>
	<keyword>cardiomyopathy</keyword>
	<keyword>familial hypertrophic cardiomyopathy</keyword>
	<keyword>heart failure</keyword>
	<keyword>cardiopulmonary exercise testing</keyword>
	<keyword>6 minute walk test</keyword>
	<keyword>perhexiline</keyword>
	<keyword>carnitine palmitoyltransferase</keyword>
	<keyword>carbohydrate utilization</keyword>
	<keyword>coronary ischemia</keyword>
	<keyword>angina</keyword>
	<keyword>mixed ion channel effect</keyword>
	<keyword>late sodium current inhibitor</keyword>
	<keyword>calcium channel inhibition</keyword>
</DOC>